Delivery Order SPE2D021DA002-SPE2D324F255W

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,558,317,054 units of doxycycline hydrochloride 100mg tablets to the Defense Logistics Agency (DLA) by the prime contractor, DMS Pharmaceutical Group Inc. The contract is a firm fixed-price delivery order valued at $10,274.04, with a period of performance ending on September 2, 2022. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois that specializes in providing a wide range of...
This federal contract award, valued at $1,430.75, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4558317055 Doxycycline Hyclate 100 mg Tablets, in quantities of 1000s. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, which runs through December 31, 2025....
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $90,021.36, is a firm fixed-price delivery order for the supply of 4,554,420 units of Doxycycline Hyclate 100mg tablets. The contract has an ultimate completion date of August 16, 2021 and is not associated with any set-aside designation. DMS...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,370.16, is for the delivery of 4,564,234,742 units of doxycycline hyclate 100 mg tablets. The contract has a firm fixed-price pricing type and a period of performance through March 29, 2024. DMS Pharmaceutical Group holds a separate,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,760.00, is a firm fixed-price delivery order for 4565242598 - Doxycycline Hyclate 100 mg Tablets (400 count). DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award, issued by the Defense Logistics Agency (DLA) under its Medical Supply Chain division, was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,709 firm fixed-price delivery order is for the supply of doxycycline hyclate, a generic antibiotic drug. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, under the SPE2DB program, that enables the agency...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract is valued at $49,600.00 and has a period of performance through May 2, 2024. The contract is for the delivery of 4,564,598,915 units of Doxycycline Hyclate 100 mg tablets in 400-count packages. This order is placed under a larger indefinite delivery contract (IDC) that DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,084.71 firm fixed-price delivery order is for the supply of Doxycycline Hyclate, a prescription medication, with a completion date of January 9, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, with a ceiling value of $1,427.25, is a delivery order contract from the Defense Logistics Agency (DLA) for the supply of Doxycycline Hyclate, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 6, 2024. Additionally, DMS Pharmaceutical Group holds a significant...
This is a $49,600 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F255W
    Delivery Order

This federal contract award, valued at $1,801.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,565,762,357 units of doxycycline hyclate 100 mg tablets.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current delivery order is a task issued under this larger IDC vehicle.

The contract has no set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business has likely contributed to its selection as the prime contractor. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a wide range of medications and medical supplies to support the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 12/11/24, 9:40 AM